Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement
- 12 September 2022
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 147 (3-4) , 158-169
Abstract
Background: Apart from ATTR amyloidosis, the epidemiology and outcomes of the most common subtypes of systemic amyloidosis in Portugal remain primarily unknown. Methods: This retrospective cohort study evaluated patients with renal biopsy-proven amyloidosis, diagnosed from January 1978 to December 2019. Follow-up started at kidney disease presentation and ended at death or August 2020. Clinical presentation, survival, and prognostic factors were analysed. Results: Of 123 patients with amyloid nephropathy, 111 had definite amyloid typing and were analysed. AA amyloidosis was the most frequent type (56.1%) and was related mainly to chronic infection (47.8%) and chronic inflammatory arthritis (29.0%). AL amyloidosis was present in 25.2% of patients and hereditary forms in 6.5% (4.1% AFibE526V, 2.4% ATTRV30M). During follow-up, 73.9% of AA and 54.8% of AL patients progressed to end-stage renal disease, and 79.7% of AA and 77.4% of AL died; median overall survival was 66.0 (95% CI, 33.0–99.0) and 18.0 (95% CI, 9.3–26.7) months (p = 0.025), respectively. There were no significant differences in renal outcome and survival on dialysis between these two types. In multivariate analysis, cardiac involvement at presentation (HR 6.26 [95% CI, 2.89–13.56]) and estimated glomerular filtration rate 2 (HR 2.05 [95% CI, 1.06–3.99]) independently influenced AA and AL amyloidosis survival. Cardiac involvement at presentation was an independent predictor of death (HR 9.65 [95% CI, 2.91–31.95]) and early mortality in AL amyloidosis. Conclusions: In Portugal, AA amyloidosis and related chronic infections are still relevant. Regarding AL amyloidosis, the low incidence and advanced disease at presentation result from missed and erroneous diagnoses, leading to delayed referrals and poor outcomes in these patients.Keywords
This publication has 39 references indexed in Scilit:
- Renal AmyloidosisClinical Journal of the American Society of Nephrology, 2013
- CyBorD: stellar response rates in AL amyloidosisBlood, 2012
- Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patientsBlood, 2012
- Prevalence and Origin of Amyloid in Kidney BiopsiesAmerican Journal of Surgical Pathology, 2009
- Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing DialysisClinical Journal of the American Society of Nephrology, 2008
- Natural History and Outcome in Systemic AA AmyloidosisNew England Journal of Medicine, 2007
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Molecular Mechanisms of AmyloidosisNew England Journal of Medicine, 2003
- Misdiagnosis of Hereditary Amyloidosis as AL (Primary) AmyloidosisNew England Journal of Medicine, 2002
- Hereditary renal amyloidosis with a novel variant fibrinogen.Journal of Clinical Investigation, 1994